The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Miltenyi Biotec Inc for a one-year preventative maintenance service for CliniMACS® Plus devices. The contract will cover maintenance for five specific serial numbers of the CliniMACS® Plus instruments, which are critical for the manufacture of cell-based therapies for patients with advanced metastatic cancer involved in clinical trials. This procurement is essential as Miltenyi Biotec is the only authorized provider capable of delivering the necessary maintenance services and software updates, ensuring the operational integrity of these vital instruments. Interested parties may submit capability statements to Sheri Eiri at sheri.eiri@nih.gov by September 30, 2024, at 12:00 PM EST, although funding for this requirement is currently not available.